<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01470235</url>
  </required_header>
  <id_info>
    <org_study_id>Hypodontovariancancer2011</org_study_id>
    <nct_id>NCT01470235</nct_id>
  </id_info>
  <brief_title>Hypodontia and Ovarian Cancer</brief_title>
  <official_title>Hypodontia and Ovarian Cancer - the Connection Between Dental Agenesis and Epithelial Cancers, Especially Ovarian Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arvid-Nilsson Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to examine whether the risk of developing ovarian cancer is
      increased in Danish women with congenital missing teeth as a result of their failure to
      develop (hypodontia). Should this prove to be the case, these women could be offered regular
      clinical controls and prophylactic removal of their ovaries when menopause enters and the
      ovaries are no longer functional (producing hormones).

      If there is a connection between congenital hypodontia and the development of different types
      of cancer, the investigators will perform a genetic screening in families with increased risk
      of cancer and hypodontia for changes in relevant genes, based on the current literature. The
      investigators hereby search for new genes, which in a changed form leads to an increased risk
      of cancer and thereby enables us to perform genetic screening in risk families.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence rates of hypodontia in women with ovarian cancer</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Genetic causes for hypodontia and ovarian cancer</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence rates of hypodontia in patients with a known risk for epithelial cancer</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Ovarian Cancer</condition>
  <condition>Hypodontia</condition>
  <condition>Breast Cancer</condition>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Ovarian Cancer</arm_group_label>
    <description>Women treated for ovarian cancer at the departments of obstetrics and gynecology, Aarhus University Hospital and Rigshospitalet, Copenhagen.
Expected recruitment: 200</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control patients</arm_group_label>
    <description>Women referred to the departments of obstetrics and gynecology in Aarhus University Hospital and Rigshospitalet, Copenhagen on benign indication.
Expected recruitment: 200.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HBOC/HNPCC</arm_group_label>
    <description>Patients registered in the large Danish Register of HBOC( hereditary breast and ovarian cancer) and HNPCC (hereditary nonpolyposis colorectal cancer).
Expected recruitment: 200.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      5ml EDTA full blood for DNA analysis.

      1 PAX-tube for RNA analysis. Biopsi from removed tumor-tissue for DNA analysis. Both
      preserved in Danish Cancer Biobank for later analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All women referred to the department of obstetrics/gynecology under the diagnosis ovarian
        cancer obs. pro.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed suspicion of ovarian cancer.

        Exclusion Criteria:

          -  suspicion of ovarian cancer disproved.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Blaakaer, Professor, MD, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Cathrine C. V. Schmidt, MD, Ph.d.-student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charlotte Soegaard, MD, ph.d.</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lone Sunde, Associate Professor, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claus Hoegdall, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Copenhagen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michala O. Lexner, Dentist, PhD</last_name>
    <role>Study Chair</role>
  </overall_official>
  <overall_contact>
    <last_name>Maria Cathrine C. V. Schmidt, MD, PhD-student</last_name>
    <phone>+4578453472</phone>
    <email>Maria.Cathrine.C.V.Schmidt@sun.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan Blaakaer, Professor</last_name>
    <phone>+4578450000</phone>
    <email>jab@dadlnet.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Skejby</city>
        <state>Aarhus</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cathrine C. V. Schmidt, MD, Ph.d-student</last_name>
      <phone>+4578453427</phone>
      <email>maria.cathrine.c.v.schmidt@ki.au.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Copenhagen University Hospital</name>
      <address>
        <city>Copenhagen Ø</city>
        <state>Copenhagen</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cathrine C.V. Schmidt, MD, Ph.d.-student</last_name>
      <phone>+4578453427</phone>
      <email>maria.cathrine.c.v.schmidt@ki.au.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Chalothorn LA, Beeman CS, Ebersole JL, Kluemper GT, Hicks EP, Kryscio RJ, DeSimone CP, Modesitt SC. Hypodontia as a risk marker for epithelial ovarian cancer: a case-controlled study. J Am Dent Assoc. 2008 Feb;139(2):163-9.</citation>
    <PMID>18245684</PMID>
  </reference>
  <reference>
    <citation>Eisinger F, Burke W, Sobol H. Management of women at high genetic risk of ovarian cancer. Lancet. 1999 Nov 6;354(9190):1648.</citation>
    <PMID>10560705</PMID>
  </reference>
  <reference>
    <citation>Cobourne MT. Familial human hypodontia--is it all in the genes? Br Dent J. 2007 Aug 25;203(4):203-8. Review.</citation>
    <PMID>17721480</PMID>
  </reference>
  <reference>
    <citation>Rølling S. Hypodontia of permanent teeth in Danish schoolchildren. Scand J Dent Res. 1980 Oct;88(5):365-9.</citation>
    <PMID>6936762</PMID>
  </reference>
  <reference>
    <citation>Rølling S, Poulsen S. Oligodontia in Danish schoolchildren. Acta Odontol Scand. 2001 Apr;59(2):111-2.</citation>
    <PMID>11370748</PMID>
  </reference>
  <reference>
    <citation>Marchini S, Marabese M, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Fruscio R, Lissoni AA, Broggini M. DeltaNp63 expression is associated with poor survival in ovarian cancer. Ann Oncol. 2008 Mar;19(3):501-7. Epub 2007 Nov 12.</citation>
    <PMID>17998283</PMID>
  </reference>
  <reference>
    <citation>Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004 May;74(5):1043-50. Epub 2004 Mar 23.</citation>
    <PMID>15042511</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2011</study_first_submitted>
  <study_first_submitted_qc>November 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2011</study_first_posted>
  <last_update_submitted>October 31, 2013</last_update_submitted>
  <last_update_submitted_qc>October 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>screening</keyword>
  <keyword>genetic</keyword>
  <keyword>cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Anodontia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

